All News #Library
Biotech
Leyden Labs Shows Novel Antibody Nasal Spray Feasibility In Flu
04 Feb 2026 //
BUSINESSWIRE
Leyden Labs Secures €30M To Advance Nasal Spray For Viruses
02 Oct 2025 //
BUSINESSWIRE
Leyden Labs secures €20M EIB Investment for Pandemic Preparedness
03 Jun 2025 //
BUSINESSWIRE
Leyden Labs Appoints Jintanat Ananworanich As Chief Medical Officer
12 Sep 2024 //
BUSINESSWIRE

Market Place
Sourcing Support